OBJECTIVE: To evaluate whether vitamin D levels are related to the risk of developing
autoimmune diseases and whether supplementation with vitamin D can modify the course of …

OBJECTIVES:: We evaluated the epidemiologic evidence that vitamin D may be related to
human autoimmune disease risk. METHODS:: PubMed, limited to English from inception …

In this study, we assessed B cell subsets, including Bregs, during stable and active disease
in relapsing remitting multiple sclerosis (RRMS) patients and related B cell subsets to …

Neurological diseases, particularly in the context of aging, have serious impacts on quality of
life and can negatively affect bone health. The brain-bone axis is critically important for …

Identifying a reliable biomarker may accelerate diagnosis of multiple sclerosis (MS) and lead
to early management of the disease. Accumulating evidence suggest that cerebrospinal fluid …

Multiple sclerosis (MS) is the most common inflammatory, demyelinating, neurodegenerative
disorder of the central nervous system (CNS). It is widely considered a T-cell mediated …

High exposure to vitamin D may protect against development and progression of multiple
sclerosis (MS), possibly through the immunomodulatory properties of its biologically active …

Context: The active metabolite of vitamin D, 1, 25-dihydroxyvitamin D [1, 25 (OH) 2D], is a
potent modulator of immune cells in vitro. Objective: Our objective was to determine whether …

Osteopontin (OPN) and interleukin-23 (IL-23) are pro-inflammatory cytokines proposed to
play central roles to the development of multiple sclerosis (MS). The aim of this study was to …

Multiple sclerosis (MS) is a chronic inflammatory-demyelinating disease of the nervous
system. There has been mounting evidence showing that MS is associated with increased …